Dual actions of glucagon: direct stimulation and indirect inhibition of dog pancreatic secretion.
The secretory actions of glucagon on the exocrine pancreas were examined using two kinds of canine preparations. In the isolated and blood-perfused dog pancreas with venous drainage, i.a. injection of glucagon did not inhibit secretin/cholecystokinin-octapeptide (CCK-8)-stimulated pancreatic secretion, but instead dose dependently enhanced both basal and stimulated pancreatic secretion. Glucagon-induced increase of pancreatic secretion was potentiated by 3-isobutyl-1-methylxanthine. In contrast, i.v. bolus injection of glucagon (3 and 10 nmol/kg) first augmented transiently then suppressed secretin/CCK-8-stimulated pancreatic secretion while simultaneously increasing circulating plasma somatostatin immunoreactivity from 14.2 to 214 fmol/ml in anesthetized intact dogs. The inhibition of secretin/CCK-8-stimulated pancreatic secretion and elevation of plasma somatostatin immunoreactivity induced by glucagon were comparable with those due to somatostatin-14. Thus, these results indicate that glucagon stimulates pancreatic secretion directly; the inhibitory action of glucagon is indirect and appears to be related to a rise in the circulating level of somatostatin immunoreactivity.
Horiuchi
A
A
Department of Pharmacology, Shinshu University School of Medicine, Matsumoto, Japan.
Iwatsuki
K
K
Ren
L M
LM
Kuroda
T
T
Chiba
S
S
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000758:Anesthesia; D000818:Animals; D001639:Bicarbonates / Q000378:metabolism; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D005934:Glucagon / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010189:Pancreatic Juice / Q000187:drug effects / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D012633:Secretin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D012844:Sincalide / Q000494:pharmacology; D013004:Somatostatin / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology
D001639:Bicarbonates; D011506:Proteins; D012633:Secretin; D013004:Somatostatin; D005934:Glucagon; D012844:Sincalide; D015056:1-Methyl-3-isobutylxanthine